Neurocrine Biosciences (NBIX) Insider Trading & Ownership $116.08 +0.56 (+0.48%) (As of 10/25/2024 08:57 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)17Amount OfInsider Selling(Last 12 Months)$80.09 M Get NBIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBIX Insider Buying and Selling by Quarter Ad DTIThe gold trades I'm making right nowBack in November, gold made a tiny move of 1.6%. But using a special type of gold trade, I saw a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there were smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period.It's all about catching what I call "Acceleration Cycles." Neurocrine Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/15/2024William H RastetterDirectorSell14,250$146.69$2,090,332.50 8/13/2024Gary A LyonsDirectorSell11,570$150.43$1,740,475.10 8/13/2024Ingrid DelaetInsiderSell7,143$150.10$1,072,164.30 8/13/2024Matt AbernethyCFOSell14,100$150.38$2,120,358.00 8/6/2024Ingrid DelaetInsiderSell273$147.70$40,322.10 8/1/2024Julie CookeInsiderSell12,632$153.26$1,935,980.32 The real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows,7/16/2024Gary A LyonsDirectorSell930$150.03$139,527.90 7/16/2024Julie CookeInsiderSell900$150.04$135,036.00 7/1/2024Julie CookeInsiderSell10,000$140.19$1,401,900.00 5/29/2024Stephen A SherwinDirectorSell40,000$133.46$5,338,400.00 5/17/2024Shalini SharpDirectorSell1,106$141.90$156,941.40 5/15/2024Matt AbernethyCFOSell15,000$140.24$2,103,600.00 5/14/2024Gary A LyonsDirectorSell12,500$135.63$1,695,375.00 5/6/2024Ingrid DelaetInsiderSell273$140.55$38,370.15 4/15/2024Eric BenevichInsiderSell19,818$133.36$2,642,928.48 3/21/2024Ingrid DelaetInsiderSell5,000$145.06$725,300.00 3/14/2024Eric BenevichInsiderSell75,000$139.38$10,453,500.00 3/14/2024George J. MorrowDirectorSell40,000$139.42$5,576,800.00 3/11/2024Ingrid DelaetInsiderSell200$140.00$28,000.00 3/11/2024Richard F PopsDirectorSell100$140.00$14,000.00 3/8/2024Ingrid DelaetInsiderSell1,800$140.03$252,054.00 3/8/2024Richard F PopsDirectorSell1,700$140.05$238,085.00 2/29/2024Ingrid DelaetInsiderSell273$135.51$36,994.23 2/27/2024Leslie V. NorwalkDirectorSell8,000$135.67$1,085,360.00 2/20/2024Richard F PopsDirectorSell15,000$132.47$1,987,050.00 2/13/2024Eiry RobertsInsiderSell1,114$132.96$148,117.44 2/13/2024Kevin Charles GormanCEOSell2,832$133.02$376,712.64 2/13/2024Matt AbernethyCFOSell1,352$132.85$179,613.20 2/8/2024David W BoyerInsiderSell1,328$135.41$179,824.48 2/8/2024Kevin Charles GormanCEOSell2,274$134.15$305,057.10 2/8/2024Matt AbernethyCFOSell980$134.21$131,525.80 2/6/2024David W BoyerInsiderSell456$141.96$64,733.76 2/6/2024Kevin Charles GormanCEOSell3,040$142.18$432,227.20 2/6/2024Matt AbernethyCFOSell1,280$142.19$182,003.20 1/31/2024Eiry RobertsInsiderSell1,457$140.79$205,131.03 1/31/2024Kevin Charles GormanCEOSell2,707$140.69$380,847.83 1/31/2024Matt AbernethyCFOSell1,283$140.72$180,543.76 1/22/2024Darin LippoldtInsiderSell10,000$139.86$1,398,600.00 1/8/2024Kevin Charles GormanCEOSell105,835$132.44$14,016,787.40 1/2/2024Kyle GanoInsiderSell75,000$131.47$9,860,250.00 The real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows,1/2/2024William H RastetterDirectorSell11,044$131.47$1,451,954.68 12/22/2023Eiry RobertsInsiderSell10,000$126.74$1,267,400.00 12/12/2023Eiry RobertsInsiderSell13,925$120.30$1,675,177.50 12/8/2023Eiry RobertsInsiderSell300$120.10$36,030.00 12/6/2023Darin LippoldtInsiderSell20,830$119.86$2,496,683.80 12/1/2023Gary A LyonsDirectorSell5,000$116.77$583,850.00 11/29/2023Jude OnyiaInsiderSell2,331$113.57$264,731.67 11/27/2023Darin LippoldtInsiderSell10,919$112.27$1,225,876.13 (Data available from 1/1/2013 forward) NBIX Insider Trading Activity - Frequently Asked Questions Who is on Neurocrine Biosciences's Insider Roster? The list of insiders at Neurocrine Biosciences includes Darin Lippoldt, David W Boyer, Eiry Roberts, Eric Benevich, Gary A Lyons, George J. Morrow, Ingrid Delaet, Jude Onyia, Julie Cooke, Kevin Charles Gorman, Kyle Gano, Leslie V. Norwalk, Malcolm Lloyd-Smith, Matt Abernethy, Neurocrine Biosciences Inc, Richard F Pops, Shalini Sharp, Stephen A Sherwin, and William H Rastetter. Learn more on insiders at NBIX. What percentage of Neurocrine Biosciences stock is owned by insiders? 4.30% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings. Which Neurocrine Biosciences insiders have been buying company stock? The following insider purchased NBIX shares in the last 24 months: Neurocrine Biosciences Inc ($39,032,821.44). How much insider buying is happening at Neurocrine Biosciences? Insiders have purchased a total of 4,395,588 NBIX shares in the last 24 months for a total of $39,032,821.44 bought. Which Neurocrine Biosciences insiders have been selling company stock? The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($6,886,900.29), David W Boyer ($700,550.20), Eiry Roberts ($4,982,223.40), Eric Benevich ($22,773,449.17), Gary A Lyons ($7,006,028.00), George J. Morrow ($5,576,800.00), Ingrid Delaet ($2,347,065.90), Jude Onyia ($608,100.93), Julie Cooke ($4,748,356.97), Kevin Charles Gorman ($17,369,891.33), Kyle Gano ($9,860,250.00), Leslie V. Norwalk ($1,085,360.00), Matt Abernethy ($7,963,690.98), Richard F Pops ($2,239,135.00), Shalini Sharp ($156,941.40), Stephen A Sherwin ($8,904,200.00), and William H Rastetter ($4,707,062.54). How much insider selling is happening at Neurocrine Biosciences? Insiders have sold a total of 834,932 Neurocrine Biosciences shares in the last 24 months for a total of $107,916,006.11 sold. Neurocrine Biosciences Key ExecutivesDr. Kevin C. Gorman Ph.D. (Age 66)CEO & Director Compensation: $2.05MMr. Matthew C. Abernethy (Age 44)Chief Financial Officer Compensation: $1.06MDr. Jude Onyia Ph.D. (Age 60)Chief Scientific Officer Compensation: $1.22MMr. Kyle W. Gano Ph.D. (Age 51)Chief Business Development & Strategy Officer Compensation: $990.12kDr. Eiry Wyn Roberts M.D. (Age 60)Chief Medical Officer Compensation: $1.12MJane SorensenHead of Investor RelationsMr. Darin M. Lippoldt Esq. (Age 58)Chief Legal Officer & Corporate Secretary Compensation: $921.01kMs. Julie S. Cooke (Age 58)Chief Human Resources Officer 3 recent tradesMr. Eric S. Benevich (Age 59)Chief Commercial Officer Compensation: $805kMr. David Warren Boyer (Age 44)Chief Corporate Affairs Officer More Insider Trading Tools from MarketBeat Related Companies Bio-Techne Insider Buying CRISPR Therapeutics Insider Buying Denali Therapeutics Insider Buying Adaptive Biotechnologies Insider Buying Alnylam Pharmaceuticals Insider Buying Biogen Insider Buying United Therapeutics Insider Buying Incyte Insider Buying BioMarin Pharmaceutical Insider Buying Exact Sciences Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideInsiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 Stocks This page (NASDAQ:NBIX) was last updated on 10/28/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredCountdown to Chaos begins WednesdayWill it be Trump or Harris? In an exclusive interview on Wednesday, October 30, at 8 p.m. ET, he’ll explain...Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)27 of the world's brightest minds in crypto are gathering to reveal their top picks and predictions for the ma...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
